Letters Section Editor: Jody W. Zylke, MD, Senior Editor.
Author Affiliations: Centre for Public Health Research, Public Health Board, Valencia, Spain (Dr Rebagliato; firstname.lastname@example.org); Department of Public Health, History of Medicine and Gynecology, Universidad Miguel Hernandez, Alicante, Spain (Dr Vioque); and Section of Endocrinology and Nutrition, Hospital Universitario de Álava-Arabako Unibertsitate Ospitalea, Vitoria-Gasteiz, Spain (Dr Arrizabalaga).
To the Editor: Dr Stagnaro-Green and colleagues1 summarized the recommendations of different scientific societies supporting the use of supplements containing 150 μg/d of potassium iodide for all pregnant women in the United States. The authors supported this recommendation on the grounds that “in the most recent national survey, the median urinary iodine level for pregnant women was only 125 μg/L” and because “the addition of 150 μg of potassium iodide does not pose a risk, even for women who are iodine replete. . . . ” In our opinion, these 2 statements may be open to debate.
Rebagliato M, Vioque J, Arrizabalaga JJ. Iodine Supplements During and After Pregnancy. JAMA. 2013;309(13):1345-1346. doi:10.1001/jama.2013.2246